$ICN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VALEANT PHARMACEUTICALS INTERNATIONAL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VALEANT PHARMACEUTICALS INTERNATIONAL. Get notifications about new insider transactions in VALEANT PHARMACEUTICALS INTERNATIONAL for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 03 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 366 | 0 | 26,169 | 25.8 K to 26.2 K (+1.42 %) |
Oct 01 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 74 | 0 | 21,038 | 21 K to 21 K (+0.35 %) |
Oct 01 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 37 | 0 | 25,803 | 25.8 K to 25.8 K (+0.14 %) |
Sep 25 2008 | ICN | VALEANT PHARMACEUT ... | HealthCor Management, L.P. | 10% Owner | Option Exercise | X | 20.00 | 5,000 | 100,000 | 0 | |
Sep 25 2008 | ICN | VALEANT PHARMACEUT ... | HealthCor Management, L.P. | 10% Owner | Buy | X | 20.00 | 500,000 | 10,000,000 | 9,000,000 | 8.5 M to 9 M (+5.88 %) |
Sep 10 2008 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP and General Cou ... | Grant | A | 0.00 | 3,641 | 0 | 22,950 | 19.3 K to 23 K (+18.86 %) |
Sep 02 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 711 | 0 | 21,004 | 20.3 K to 21 K (+3.50 %) |
Sep 02 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 560 | 0 | 25,886 | 25.3 K to 25.9 K (+2.21 %) |
Aug 19 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Grant | A | 0.00 | 51,440 | 0 | 845,218 | 793.8 K to 845.2 K (+6.48 %) |
Aug 19 2008 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Grant | A | 0.00 | 2,160 | 0 | 25,280 | 23.1 K to 25.3 K (+9.34 %) |
Aug 11 2008 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP and General Cou ... | Buy | P | 19.55 | 1,705 | 33,333 | 11,475 | 9.8 K to 11.5 K (+17.45 %) |
Aug 04 2008 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP and General Cou ... | Buy | P | 17.22 | 1,936 | 33,338 | 9,770 | 7.8 K to 9.8 K (+24.71 %) |
Jul 30 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 391 | 0 | 20,293 | 19.9 K to 20.3 K (+1.96 %) |
Jul 30 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 298 | 0 | 25,326 | 25 K to 25.3 K (+1.19 %) |
Jul 28 2008 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP and General Cou ... | Buy | P | 17.64 | 1,890 | 33,340 | 7,834 | 5.9 K to 7.8 K (+31.80 %) |
Jul 21 2008 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP and General Cou ... | Buy | P | 17.29 | 1,928 | 33,335 | 5,944 | 4 K to 5.9 K (+48.01 %) |
Jul 15 2008 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP and General Cou ... | Buy | P | 16.99 | 1,962 | 33,334 | 4,016 | 2.1 K to 4 K (+95.52 %) |
Jul 11 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Grant | A | 0.00 | 198,013 | 0 | 793,778 | 595.8 K to 793.8 K (+33.24 %) |
Jul 11 2008 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Grant | A | 0.00 | 8,342 | 0 | 23,120 | 14.8 K to 23.1 K (+56.45 %) |
Jul 10 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Grant | A | 0.00 | 50,906 | 0 | 396,817 | 345.9 K to 396.8 K (+14.72 %) |
Jul 10 2008 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Grant | A | 0.00 | 2,138 | 0 | 6,433 | 4.3 K to 6.4 K (+49.78 %) |
Jul 08 2008 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP and General Cou ... | Buy | P | 16.23 | 2,054 | 33,336 | 2,054 | 0 to 2.1 K |
Jul 07 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Buy | P | 16.20 | 51,440 | 833,328 | 544,859 | 493.4 K to 544.9 K (+10.43 %) |
Jul 07 2008 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Buy | P | 16.20 | 2,160 | 34,992 | 12,640 | 10.5 K to 12.6 K (+20.61 %) |
Jul 01 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 445 | 0 | 19,937 | 19.5 K to 19.9 K (+2.28 %) |
Jul 01 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 445 | 0 | 25,116 | 24.7 K to 25.1 K (+1.80 %) |
Jun 30 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 410 | 0 | 19,492 | 19.1 K to 19.5 K (+2.15 %) |
Jun 30 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 264 | 0 | 24,671 | 24.4 K to 24.7 K (+1.08 %) |
Jun 27 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Buy | P | 17.09 | 48,761 | 833,325 | 493,419 | 444.7 K to 493.4 K (+10.97 %) |
Jun 27 2008 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & CHIEF ADMINIS ... | Buy | P | 17.08 | 2,049 | 34,997 | 10,480 | 8.4 K to 10.5 K (+24.30 %) |
Jun 20 2008 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & CHIEF ADMINIS ... | Buy | P | 17.02 | 2,056 | 34,993 | 8,431 | 6.4 K to 8.4 K (+32.25 %) |
Jun 20 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Buy | P | 17.06 | 48,847 | 833,330 | 444,658 | 395.8 K to 444.7 K (+12.34 %) |
Jun 16 2008 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & CHIEF ADMINIS ... | Buy | P | 16.83 | 2,080 | 35,006 | 6,375 | 4.3 K to 6.4 K (+48.43 %) |
Jun 16 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Buy | P | 16.70 | 49,900 | 833,330 | 395,811 | 345.9 K to 395.8 K (+14.43 %) |
Jun 09 2008 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & CHIEF ADMINIS ... | Buy | P | 16.23 | 2,157 | 35,008 | 4,295 | 2.1 K to 4.3 K (+100.89 %) |
Jun 09 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Buy | P | 16.50 | 50,505 | 833,333 | 345,911 | 295.4 K to 345.9 K (+17.10 %) |
Jun 03 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Buy | P | 16.37 | 50,906 | 833,331 | 295,406 | 244.5 K to 295.4 K (+20.82 %) |
Jun 03 2008 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & CHIEF ADMINIS ... | Buy | P | 16.37 | 2,138 | 34,999 | 2,138 | 0 to 2.1 K |
May 29 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 489 | 0 | 19,082 | 18.6 K to 19.1 K (+2.63 %) |
May 29 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 186 | 0 | 24,407 | 24.2 K to 24.4 K (+0.77 %) |
May 22 2008 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Grant | A | 0.00 | 7,757 | 0 | 15,464 | 7.7 K to 15.5 K (+100.65 %) |
May 22 2008 | ICN | VALEANT PHARMACEUT ... | Morfit G Mason | Director | Grant | A | 0.00 | 7,757 | 0 | 15,464 | 7.7 K to 15.5 K (+100.65 %) |
May 22 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 7,757 | 0 | 18,593 | 10.8 K to 18.6 K (+71.59 %) |
May 22 2008 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 0.00 | 7,757 | 0 | 20,464 | 12.7 K to 20.5 K (+61.05 %) |
May 22 2008 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 0.00 | 7,757 | 0 | 25,464 | 17.7 K to 25.5 K (+43.81 %) |
May 22 2008 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 0.00 | 7,757 | 0 | 17,964 | 10.2 K to 18 K (+76.00 %) |
May 22 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 10,343 | 0 | 24,221 | 13.9 K to 24.2 K (+74.53 %) |
Apr 29 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 120 | 0 | 10,836 | 10.7 K to 10.8 K (+1.12 %) |
Apr 29 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 55 | 0 | 13,878 | 13.8 K to 13.9 K (+0.40 %) |
Apr 02 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 13.28 | 706 | 9,376 | 10,716 | 10 K to 10.7 K (+7.05 %) |
Apr 02 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 13.28 | 565 | 7,503 | 13,823 | 13.3 K to 13.8 K (+4.26 %) |
Mar 31 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 12.63 | 376 | 4,749 | 10,010 | 9.6 K to 10 K (+3.90 %) |
Mar 31 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 12.63 | 178 | 2,248 | 13,258 | 13.1 K to 13.3 K (+1.36 %) |
Mar 03 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 14.43 | 702 | 10,130 | 9,634 | 8.9 K to 9.6 K (+7.86 %) |
Mar 03 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 14.43 | 312 | 4,502 | 13,080 | 12.8 K to 13.1 K (+2.44 %) |
Feb 05 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Option Exercise | A | 12.19 | 991,779 | 12,089,786 | 991,779 | |
Feb 05 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Option Exercise | A | 12.19 | 32,812 | 399,978 | 32,812 | |
Feb 05 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Grant | A | 0.00 | 81,500 | 0 | 244,500 | 163 K to 244.5 K (+50.00 %) |
Feb 05 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Grant | A | 0.00 | 163,000 | 0 | 163,000 | 0 to 163 K |
Jan 29 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 11.89 | 442 | 5,255 | 8,932 | 8.5 K to 8.9 K (+5.21 %) |
Jan 29 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 11.89 | 252 | 2,996 | 12,768 | 12.5 K to 12.8 K (+2.01 %) |
Jan 04 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 11.98 | 783 | 9,380 | 8,490 | 7.7 K to 8.5 K (+10.16 %) |
Jan 04 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 11.98 | 626 | 7,499 | 12,516 | 11.9 K to 12.5 K (+5.26 %) |
Jan 03 2008 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Sell | D | 0.00 | 7,707 | 0 | 0 | 7.7 K to 0 (-100.00 %) |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP, General Counse ... | Option Exercise | A | 14.80 | 43,244 | 640,011 | 43,244 | |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP, General Counse ... | Option Exercise | A | 14.80 | 6,756 | 99,989 | 6,756 | |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP, General Counse ... | Grant | A | 14.80 | 25,000 | 370,000 | 26,446 | 1.4 K to 26.4 K (+1,728.91 %) |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP & CFO | Option Exercise | A | 14.80 | 29,732 | 440,034 | 29,732 | |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP & CFO | Option Exercise | A | 14.80 | 20,268 | 299,966 | 20,268 | |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP & CFO | Grant | A | 14.80 | 25,000 | 370,000 | 26,000 | 1,000 to 26 K (+2,500.00 %) |
Dec 11 2007 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Sell | D | 0.00 | 25,000 | 0 | 3,446 | 28.4 K to 3.4 K (-87.89 %) |
Dec 11 2007 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Sell | D | 0.00 | 10,000 | 0 | 28,446 | 38.4 K to 28.4 K (-26.01 %) |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | Bramlage Charles | President, Europe | Option Exercise | A | 14.80 | 43,244 | 640,011 | 43,244 | |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | Bramlage Charles | President, Europe | Option Exercise | A | 14.80 | 6,756 | 99,989 | 6,756 | |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | Bramlage Charles | President, Europe | Grant | A | 14.80 | 25,000 | 370,000 | 25,000 | 0 to 25 K |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Option Exercise | A | 14.80 | 43,244 | 640,011 | 43,244 | |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Option Exercise | A | 14.80 | 6,756 | 99,989 | 6,756 | |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Grant | A | 14.80 | 25,000 | 370,000 | 28,446 | 3.4 K to 28.4 K (+725.48 %) |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | CEO and President | Option Exercise | A | 14.80 | 203,244 | 3,008,011 | 203,244 | |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | CEO and President | Option Exercise | A | 14.80 | 6,756 | 99,989 | 6,756 | |
Nov 01 2007 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | CEO and President | Grant | A | 14.80 | 105,000 | 1,554,000 | 118,496 | 13.5 K to 118.5 K (+778.01 %) |
May 24 2007 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 15.57 | 7,707 | 119,998 | 7,707 | 0 to 7.7 K |
Jun 06 2007 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | CEO and President | Sell | S | 16.47 | 300 | 4,941 | 13,496 | 13.8 K to 13.5 K (-2.17 %) |
May 24 2007 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 15.57 | 7,707 | 119,998 | 12,707 | 5 K to 12.7 K (+154.14 %) |
May 24 2007 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 15.57 | 7,707 | 119,998 | 7,707 | 0 to 7.7 K |
May 24 2007 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 15.57 | 7,707 | 119,998 | 17,707 | 10 K to 17.7 K (+77.07 %) |
May 24 2007 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 15.57 | 10,276 | 159,997 | 11,890 | 1.6 K to 11.9 K (+636.68 %) |
May 24 2007 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 15.57 | 7,707 | 119,998 | 10,207 | 2.5 K to 10.2 K (+308.28 %) |
May 24 2007 | ICN | VALEANT PHARMACEUT ... | Morfit G Mason | Director | Grant | A | 15.57 | 7,707 | 119,998 | 7,707 | 0 to 7.7 K |
Apr 10 2007 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 18.68 | 5,000 | 93,400 | 5,000 | 0 to 5 K |
Apr 09 2007 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 19.08 | 1,614 | 30,795 | 1,614 | 0 to 1.6 K |
Apr 09 2007 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 19.08 | 1,614 | 30,795 | 1,614 | 0 to 1.6 K |
Jan 03 2007 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 17.62 | 213 | 3,753 | 27,866 | 27.7 K to 27.9 K (+0.77 %) |
Jan 03 2007 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 17.62 | 213 | 3,753 | 36,189 | 36 K to 36.2 K (+0.59 %) |
Nov 30 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 16.49 | 454 | 7,486 | 27,653 | 27.2 K to 27.7 K (+1.67 %) |
Nov 30 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 16.49 | 454 | 7,486 | 35,976 | 35.5 K to 36 K (+1.28 %) |
Nov 02 2006 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Option Exercise | A | 18.68 | 84,647 | 1,581,206 | 84,647 | |
Nov 02 2006 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Option Exercise | A | 18.68 | 5,353 | 99,994 | 5,353 | |
Nov 02 2006 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | CEO and President | Option Exercise | A | 18.68 | 339,647 | 6,344,606 | 339,647 | |
Nov 02 2006 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | CEO and President | Option Exercise | A | 18.68 | 5,353 | 99,994 | 5,353 | |
Nov 02 2006 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP, General Counse ... | Option Exercise | A | 18.68 | 84,647 | 1,581,206 | 84,647 | |
Nov 02 2006 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP, General Counse ... | Option Exercise | A | 18.68 | 5,353 | 99,994 | 5,353 | |
Nov 02 2006 | ICN | VALEANT PHARMACEUT ... | Bramlage Charles | President, European ... | Option Exercise | A | 18.68 | 84,647 | 1,581,206 | 84,647 | |
Nov 02 2006 | ICN | VALEANT PHARMACEUT ... | Bramlage Charles | President, European ... | Option Exercise | A | 18.68 | 5,353 | 99,994 | 5,353 | |
Oct 31 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 18.99 | 195 | 3,703 | 27,199 | 27 K to 27.2 K (+0.72 %) |
Nov 02 2006 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Option Exercise | A | 18.68 | 94,647 | 1,768,006 | 94,647 | |
Nov 02 2006 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Option Exercise | A | 18.68 | 5,353 | 99,994 | 5,353 | |
Oct 31 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 18.99 | 195 | 3,703 | 35,522 | 35.3 K to 35.5 K (+0.55 %) |
Oct 13 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.73 | 81,000 | 1,598,130 | 11,857,600 | 11.8 M to 11.9 M (+0.69 %) |
Oct 13 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.65 | 905,400 | 17,791,110 | 11,776,600 | 10.9 M to 11.8 M (+8.33 %) |
Oct 13 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.73 | 9,000 | 177,570 | 1,383,700 | 1.4 M to 1.4 M (+0.65 %) |
Oct 13 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.65 | 100,600 | 1,976,790 | 1,374,700 | 1.3 M to 1.4 M (+7.90 %) |
Oct 13 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.73 | 100,000 | 1,973,000 | 1,274,100 | 1.2 M to 1.3 M (+8.52 %) |
Oct 10 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.82 | 57,600 | 1,141,632 | 1,174,100 | 1.1 M to 1.2 M (+5.16 %) |
Oct 10 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.99 | 50,000 | 999,500 | 1,116,500 | 1.1 M to 1.1 M (+4.69 %) |
Oct 10 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 20.00 | 5,600 | 112,000 | 1,066,500 | 1.1 M to 1.1 M (+0.53 %) |
Oct 04 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.70 | 1,700 | 33,490 | 1,060,900 | 1.1 M to 1.1 M (+0.16 %) |
Oct 04 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.50 | 5,200 | 101,400 | 1,059,200 | 1.1 M to 1.1 M (+0.49 %) |
Oct 04 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.66 | 100,000 | 1,966,000 | 1,054,000 | 954 K to 1.1 M (+10.48 %) |
Oct 03 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 19.60 | 478 | 9,369 | 27,004 | 26.5 K to 27 K (+1.80 %) |
Oct 03 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 19.60 | 525 | 10,290 | 35,327 | 34.8 K to 35.3 K (+1.51 %) |
Sep 29 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 19.90 | 189 | 3,761 | 26,526 | 26.3 K to 26.5 K (+0.72 %) |
Sep 29 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 19.90 | 189 | 3,761 | 34,802 | 34.6 K to 34.8 K (+0.55 %) |
Sep 29 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.84 | 40,900 | 811,456 | 954,000 | 913.1 K to 954 K (+4.48 %) |
Sep 29 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.81 | 59,100 | 1,170,771 | 913,100 | 854 K to 913.1 K (+6.92 %) |
Sep 29 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.70 | 18,000 | 354,600 | 854,000 | 836 K to 854 K (+2.15 %) |
Sep 25 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.68 | 25,000 | 492,000 | 836,000 | 811 K to 836 K (+3.08 %) |
Sep 25 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.62 | 75,000 | 1,471,500 | 811,000 | 736 K to 811 K (+10.19 %) |
Sep 25 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 20.00 | 100,000 | 2,000,000 | 736,000 | 636 K to 736 K (+15.72 %) |
Sep 25 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.96 | 50,000 | 998,000 | 636,000 | 586 K to 636 K (+8.53 %) |
Sep 19 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.86 | 106,200 | 2,109,132 | 586,000 | 479.8 K to 586 K (+22.13 %) |
Sep 19 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 20.01 | 25,000 | 500,250 | 479,800 | 454.8 K to 479.8 K (+5.50 %) |
Sep 19 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 20.02 | 75,000 | 1,501,500 | 454,800 | 379.8 K to 454.8 K (+19.75 %) |
Sep 14 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 20.00 | 110,000 | 2,200,000 | 379,800 | 269.8 K to 379.8 K (+40.77 %) |
Sep 14 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 20.00 | 18,300 | 366,000 | 269,800 | 251.5 K to 269.8 K (+7.28 %) |
Sep 14 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 18.99 | 5,000 | 94,950 | 251,500 | 246.5 K to 251.5 K (+2.03 %) |
Sep 14 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.99 | 100,000 | 1,999,000 | 246,500 | 146.5 K to 246.5 K (+68.26 %) |
Sep 11 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.43 | 83,400 | 1,620,462 | 146,500 | 63.1 K to 146.5 K (+132.17 %) |
Sep 11 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.50 | 25,000 | 487,500 | 63,100 | 38.1 K to 63.1 K (+65.62 %) |
Sep 11 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.50 | 30,000 | 585,000 | 38,100 | 8.1 K to 38.1 K (+370.37 %) |
Sep 11 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 19.50 | 8,100 | 157,950 | 8,100 | 0 to 8.1 K |
Sep 01 2006 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Grant | A | 19.66 | 40 | 786 | 180 | 140 to 180 (+28.57 %) |
Sep 01 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 19.66 | 106 | 2,084 | 544 | 438 to 544 (+24.20 %) |
Sep 01 2006 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | CEO and President | Grant | A | 19.66 | 120 | 2,359 | 541 | 421 to 541 (+28.50 %) |
Sep 01 2006 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP, General Counse ... | Grant | A | 19.66 | 40 | 786 | 180 | 140 to 180 (+28.57 %) |
Sep 01 2006 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 19.66 | 113 | 2,222 | 867 | 754 to 867 (+14.99 %) |
Sep 01 2006 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 19.66 | 113 | 2,222 | 867 | 754 to 867 (+14.99 %) |
Sep 01 2006 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 19.66 | 113 | 2,222 | 867 | 754 to 867 (+14.99 %) |
Sep 01 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 19.66 | 140 | 2,752 | 979 | 839 to 979 (+16.69 %) |
Sep 01 2006 | ICN | VALEANT PHARMACEUT ... | BURKHARDT EDWARD A | Director | Grant | A | 19.66 | 79 | 1,553 | 431 | 352 to 431 (+22.44 %) |